×
Use of Antipsychotics in the Treatment of Major Depressive Disorder in the U.S. Department of Veterans Affairs PDF
$ 40.00
Use of Antipsychotics in the Treatment of Major Depressive Disorder in the U.S. Department of Veterans Affairs PDF quantity
$ 40.00
×
Number Needed to Treat to Harm for Discontinuation Due to Adverse Events in the Treatment of Bipolar Depression, Major Depressive Disorder, and Generalized Anxiety Disorder With Atypical Antipsychotics PDF
$ 40.00
Number Needed to Treat to Harm for Discontinuation Due to Adverse Events in the Treatment of Bipolar Depression, Major Depressive Disorder, and Generalized Anxiety Disorder With Atypical Antipsychotics PDF quantity
$ 40.00
×
Quality of Life Following Remission of Mental Disorders: Findings From the National Epidemiologic Survey on Alcohol and Related Conditions PDF
$ 40.00
Quality of Life Following Remission of Mental Disorders: Findings From the National Epidemiologic Survey on Alcohol and Related Conditions PDF quantity
$ 40.00
×
On the Threshold of Disorder: A Study of the Impact of the DSM-IV Clinical Significance Criterion on Diagnosing Depressive and Anxiety Disorders in Clinical Practice. PDF
$ 40.00
On the Threshold of Disorder: A Study of the Impact of the DSM-IV Clinical Significance Criterion on Diagnosing Depressive and Anxiety Disorders in Clinical Practice. PDF quantity
$ 40.00
×
Association of Obesity and Inflammatory Marker Levels on Treatment Outcome: Results From a Double-Blind, Randomized Study of Adjuncve L-Methylfolate Calciumin Paents With MDD Who Are Inadequate Responders to SSRIs PDF
$ 40.00
Association of Obesity and Inflammatory Marker Levels on Treatment Outcome: Results From a Double-Blind, Randomized Study of Adjuncve L-Methylfolate Calciumin Paents With MDD Who Are Inadequate Responders to SSRIs PDF quantity
$ 40.00
×
Effects of Parental Opioid Use: Outcomes of Children of Parents in Medication-Assisted Treatment Compared to Healthy Controls PDF
$ 40.00
Effects of Parental Opioid Use: Outcomes of Children of Parents in Medication-Assisted Treatment Compared to Healthy Controls PDF quantity
$ 40.00
×
Safety and Feasibility of Repetitive Transcranial Magnetic Stimulation in the Treatment of Anxious Depression in Pregnancy: A Case Report PDF
$ 40.00
Safety and Feasibility of Repetitive Transcranial Magnetic Stimulation in the Treatment of Anxious Depression in Pregnancy: A Case Report PDF quantity
$ 40.00
×
Evidence for Efficacy and Tolerability of Vilazodone in the Treatment of Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial PDF
$ 40.00
Evidence for Efficacy and Tolerability of Vilazodone in the Treatment of Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial PDF quantity
$ 40.00
×
Sexual Satisfaction and Quality of Life in Major Depressive Disorder Before and After Treatment With Citalopram in the STAR*D Study PDF
$ 40.00
Sexual Satisfaction and Quality of Life in Major Depressive Disorder Before and After Treatment With Citalopram in the STAR*D Study PDF quantity
$ 40.00
×
The Impact of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) on Prescribing Practices: An Analysis of Data From a Large Midwestern State PDF
$ 40.00
The Impact of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) on Prescribing Practices: An Analysis of Data From a Large Midwestern State PDF quantity
$ 40.00
×
The Safety of Olanzapine in Adolescents With Schizophrenia or Bipolar I Disorder: A Pooled Analysis of 4 Clinical Trials PDF
$ 40.00
The Safety of Olanzapine in Adolescents With Schizophrenia or Bipolar I Disorder: A Pooled Analysis of 4 Clinical Trials PDF quantity
$ 40.00
×
A Meta-Analysis of the Risk of Acute Extrapyramidal Symptoms With Intramuscular Antipsychotics for the Treatment of Agitation PDF
$ 40.00
A Meta-Analysis of the Risk of Acute Extrapyramidal Symptoms With Intramuscular Antipsychotics for the Treatment of Agitation PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
